北米のカンナビジオール (CBD) 市場 - 原料 (麻とマリファナ)、グレード (食品グレードと治療グレード)、性質 (有機と無機)、用途 (チンキ剤、食品、飲料、医薬品、外用剤、栄養補助食品など)、製品タイプ (CBD オイル、CBD 濃縮物、CBD 分離物など) 別 - 2029 年までの業界動向と予測。
北米カンナビジオール（CBD）市場分析と洞察
北米のカンナビジオール（CBD）市場は、2022年から2029年の予測期間に市場の成長が見込まれています。データブリッジマーケットリサーチは、市場は2022年から2029年の予測期間に28.7％のCAGRで成長すると分析しています。カンナビジオール（CBD）薬物治療の技術的進歩、ヘルスケア部門の増加は、予測期間中の北米のカンナビジオール（CBD）市場の成長を促進するもう1つの要因です。
しかし、CBD オイルに関連する副作用や、市場で入手可能な偽造品や合成品は、市場の成長を抑制します。主要な市場プレーヤーによるパートナーシップや買収などの戦略的提携の採用は、北米のカンナビジオール (CBD) 市場の成長の機会として機能します。
|
レポートメトリック |
詳細 |
|
予測期間 |
2022年から2029年 |
|
基準年 |
2021 |
|
歴史的な年 |
2020 (2019～2014 にカスタマイズ可能) |
|
定量単位 |
売上高は百万米ドル、価格は米ドル |
|
対象セグメント |
原料（麻とマリファナ）、グレード（食品グレードと治療グレード）、性質（有機と無機）、用途（チンキ剤、食品、飲料、医薬品、外用剤、栄養補助食品など）、製品タイプ（CBDオイル、CBD濃縮物、CBD単離物など） |
|
対象国 |
米国、カナダ、メキシコ |
|
対象となる市場プレーヤー |
北米のカンナビジオール（CBD）市場で活動している主要企業には、CV Sciences、Inc.、VIVO Cannabis Inc.、Gaia Herbs Hemp、Phoena Holdings Inc.、Medical Marijuana、Inc.、The Cronos Group、CHARLOTTE'S WEB、HEXO Corp.、Aurora Cannabis、Canopy Growth Corporation、Jazz Pharmaceuticals、Inc.、Tilray、Curaleaf、KAZMIRA、Freedom Leaf、Inc.、Koi CBD、Groff North America Hemplex、Joy Organics、Elixinol Wellness Limited、Isodiol International Inc.、Healthy Food Ingredients、LLC、NuLeaf Naturals、LLC、Diamond CBD、Medterra CBD、ENDOCA、Green Roads などがあります。 |
カンナビジオール（CBD）市場の定義
カンナビジオール（CBD）は、大麻サティバ植物に含まれる化合物で、麻または大麻から抽出されます。通常は、天然のカンナビジオール（CBD）含有量が高いため、麻から抽出されます。不安や発作の治療、痛みの軽減にいくつかの利点があります。その治癒特性により、健康とウェルネス目的でのCBDの需要が高く、これが市場を牽引する主な要因となっています。すべてのカンナビノイドのうち、カンナビジオールは精神活性効果がないため、治療目的で最も広く使用されています。多くの医療用途で、不安やうつ病の治療、ストレス緩和、糖尿病予防、痛みの緩和、癌症状の緩和、炎症など、カンナビジオールオイルが使用されています。病気の治療にCBDベースの製品がますます採用されているため、北米市場は予測期間中に有利な速度で成長すると予想されています。カンナビジオールオイルは、ニキビやシワを治療するためのスキンケア製品の製造にますます使用されています。たとえば、セフォラは最近、カンナビジオールまたは CBD スキンケア ラインを店舗に導入しました。同様に、アルタ ビューティーはカンナビジオール ベースの製品ラインを発売する予定です。また、カンナビジオール配合の化粧品市場には、いくつかの新しい企業も参入しています。
さらに、さまざまな国の政府やカンナビノイド市場の主要企業が研究開発活動に投資しています。いくつかの臨床試験では、CBDはてんかんを含むさまざまな神経疾患の効果的な治療薬であると言われています。
市場の動向
ドライバー
- 健康とフィットネスにおけるCBDの需要増加
消費者の健康とフィットネスに関する意識の高まりは、CBD 市場の急速な成長を促すでしょう。医療用大麻の合法化とともに消費者の可処分所得が増加することで、この分野におけるカンナビジオールの需要にプラスの影響を与えることが予想されます。
さらに、CBD製品は、不安/ストレス、睡眠/不眠症、慢性疼痛、片頭痛、スキンケア、発作、関節痛と炎症、神経疾患など、さまざまな問題の緩和に使用されています。慢性疼痛治療は、CBDを使用することで得られる追加の利点により、非常に人気が高まっています。カンナビジオール（CBD）製品は、その広範な医療用途と疼痛緩和治療により、近年需要が高まっています。CBDは、体内のさまざまな生物学的プロセスに作用することで、慢性疼痛を軽減するのに役立ちます。さらに、CBDには抗酸化作用、抗炎症作用、鎮痛作用があります。したがって、CBD製品は、慢性疼痛に苦しむ人々が経験する不安を軽減します。したがって、慢性疼痛治療におけるCBDの需要の増加は、市場の成長を促進しています。これは、フィットネス活動中に発生する可能性のある痛みを避けながら、人々が健康とフィットネスのルーチンを維持するのにも役立ちます。
- CBD製品に対する政府の承認と規制の改善
There are strict government regulations and CBD based products required strict approvals before they were marketed and supplied in the local as well international market, which limited the growth of the market. However, with time these restrictions have been eased up and there has been increasing acceptance of refined CBD products combined with the increasing legalization of marijuana and marijuana-derived products for various applications. This will drive the growth and demand in the market.
Moreover, there is the presence of major manufacturers of CBD products across the globe which has further induced the government and other regulatory bodies such as Food and Drug Administration (F.D.A.) in the U.S., European Union in Europe, etc. to ease up the restrictions for CBD and CBD based products.
Restraint
-
High cost of CBD products
CBD is a popular and a holistic choice for people struggling with pain, inflammation, and sleep problems. Since CBD is a new product with less research and development and has lately been regulated and approved, therefore, the price of CBD are subject to fluctuations. The production of hemp became legal in 2018, which affected the price of CBD products. As a result, various CBD products witnessed some price inflation.
Moreover, many farmers are transitioning towards growing and selling hemp used to make CBD products, but despite the increased popularity of this product, it presents its own agricultural challenges. Firstly, switching over to a new crop results in new expenses. The most efficient way to harvest hemp is using a combine harvester. However, farmers who have previously grown crops that don’t require combines, such as strawberries, can’t afford to purchase a combine right away. Therefore, they need to hire people to help harvest the hemp, which drives up overall product prices as the raw material becomes costly.
Additionally, hemp requires more time and labor to grow and farmers need to inspect their crop closely as it grows. Furthermore, once it is harvested, extracting the cannabidiol is a difficult and expensive process. The processors and extractors of CBD need to use either ethanol or supercritical carbon dioxide (CO2 extraction). The extraction and refinement process requires special machinery and takes a long time, which drives up the CBD cost. Thus, all these factors add up to the costs of CBD products making them much more costly than other products, which is likely to restrain the market’s demand.
Opportunity
-
Increasing investments in development of new CBD based products
With the increasing trend of providing innovative and refined products in the market, manufacturers are spending large amounts in research and development for the production of new CBD based products. Oils, tinctures, concentrate, capsules, topical solutions such as slaves, lip balms, lotions, and edibles such as baked goods, coffee, chocolates, gums, and candies are some of the CBD products which are in high demand.
The increasing demand has increased the number of trials to study the impact of CBD on certain health conditions, which is expected to develop new products in turn providing opportunity for the rise in the demand in the forthcoming years. Furthermore, many companies procure CBD oils in bulk and manufacture CBD-infused products. In addition, numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance.
Moreover, with the ease in regulations and post the approval of cannabis products, the companies are investing huge amounts in the product development and upgrading the raw material production, which will also help them to cut down on costs while meeting the surging demand in the market. The new product development and increasing research and development activities along with various strategic decisions taken by key manufacturers in the market will offer lucrative opportunity for the growth of the North America CBD market.
Challenge
- Side effects associated with CBD oil
Cannabidiol is well-known for its ability to cure a variety of illnesses, including anxiety, seizures, neurological problems, cancer-related nausea, chronic pain, and more. However, being useful for a variety of medical illnesses, various studies and research conducted by numerous organizations have shown that CBD-based medicines can have negative effects as well.
Some of the side effects that are commonly experienced by consumers include dry mouth, drowsiness, low blood pressure, and lightheadedness. CBD is also known to raise the level of Coumadin (a blood thinner) in the body, which can interact with other drugs and cause negative side effects. These factors might impede future adoption of CBD for therapeutic purposes.
Moreover, another cause for concern is the unreliability of the purity and dosage of CBD in products such as CBD oil. High concentration of CBD oil can also have harmful effects on the consumers’ health. In some cases, excessive use of CBD oil may also increase liver enzymes, which is a marker of liver inflammation. Cytochrome P450 (CYP450) is an enzyme which body uses to break down some drugs. CBD oil can block CYP450. That means that taking CBD oil with these drugs could make them have a stronger effect than one needs or make them not work at all.
Further, dietary supplements that contain CBD and a blend of herbal ingredients may not be safe for everyone, as many herbs have the potential to interact with commonly prescribed medications. All these side effects may vary from person to person as minor side effects for some may prove to be serious for others. This may pose as a challenge for the increasing demand of CBD products in the North America CBD market.
Post COVID-19 Impact on North America cannabidiol (CBD) market
COVID-19 により、予防措置として医療従事者と一般市民の両方から医療用品の需要が大幅に増加しました。これらのアイテムの製造業者は、市場で個人用保護具の安定した供給を確保することで、医療用品の需要増加を活かすチャンスがあります。COVID-19 は、北米のカンナビジオール (CBD) 市場に大きな影響を与えると予想されています。
北米カンナビジオール（CBD）市場の範囲と市場規模
北米のカンナビジオール (CBD) 市場は、ソース、グレード、用途、製品タイプ、性質に基づいてセグメント化されています。セグメント間の成長は、ニッチな成長分野と市場にアプローチするための戦略を分析し、コアアプリケーション領域とターゲット市場の違いを決定するのに役立ちます。
情報源別
- 麻
- マリファナ
北米のカンナビジオール（CBD）市場は、供給源に基づいて麻とマリファナに分類されます。
製品タイプ別
- CBDオイル
- CBDアイソレート
- CBD濃縮物
- その他
製品タイプに基づいて、北米のカンナビジオール（CBD）市場は、CBDオイル、CBD濃縮物、CBD単離物、その他に分類されます。
自然によって
- オーガニック
- 無機
性質に基づいて、北米のカンナビジオール (CBD) 市場は有機と無機に分類されます。
学年別
- 食品グレード
- 治療グレード
グレードに基づいて、北米のカンナビジオール (CBD) 市場は、食品グレードと治療グレードに分類されます。
アプリケーション別
- チンキ剤
- 食べ物
- 飲料
- 医薬品
- 局所用薬
- 栄養補助食品
- その他
用途に基づいて、北米のカンナビジオール (CBD) 市場は、チンキ剤、食品、飲料、医薬品、局所薬、栄養補助食品などに分類されます。
北米カンナビジオール（CBD）市場の国別分析
カンナビジオール (CBD) 市場が分析され、ソース、グレード、用途、製品タイプおよび性質別に市場規模の情報が提供されます。
カンナビジオール (CBD) 市場レポートの対象国は、米国、カナダ、メキシコです。
2022年には、高いGDPを誇る最大の消費者市場に沿って主要な市場プレーヤーが存在するため、米国が優位に立つでしょう。米国は、薬物治療における技術進歩の高まりにより成長すると予想されています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、北米ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響も考慮されます。
カンナビジオール (CBD) 市場は、ヘルスケア業界における各国の成長に関する詳細な市場分析も提供します。さらに、ヘルスケア サービスと治療、規制シナリオの影響、カンナビジオール (CBD) 市場に関するトレンド パラメータに関する詳細な情報も提供します。
競争環境と北米のカンナビジオール（CBD）市場シェア分析
北米カンナビジオール (CBD) 市場の競争状況では、競合他社ごとに詳細が提供されます。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線が含まれます。上記のデータ ポイントは、カンナビジオール (CBD) 製品に関連する会社の焦点にのみ関連しています。
カンナビジオール（CBD）市場を扱っている主要企業としては、CV Sciences, Inc.、VIVO Cannabis Inc.、Gaia Herbs Hemp、Phoena Holdings Inc.、Medical Marijuana, Inc.、The Cronos Group、CHARLOTTE'S WEB、HEXO Corp.、Aurora Cannabis、Canopy Growth Corporation、Jazz Pharmaceuticals, Inc.、Tilray、Curaleaf、KAZMIRA、Freedom Leaf, Inc.、Koi CBD、Groff North America Hemplex、Joy Organics、Elixinol Wellness Limited、Isodiol International Inc.、Healthy Food Ingredients, LLC、NuLeaf Naturals, LLC、Diamond CBD、Medterra CBD、ENDOCA、Green Roads などがあります。
主要な市場プレーヤーによる合併、買収、合意などの戦略的提携により、カンナビジオール（CBD）製品の成長がさらに加速すると予想されます。
例えば、
- 2022年5月、Canopy Growth Corporationと、カリフォルニアを拠点とする高品質大麻抽出物の生産者であり、クリーンベイプ技術の先駆者であるLemurian, Inc.は、米国でTHCの連邦政府許可が得られ次第、またはCanopy Growthの選択によりそれ以前に、Jettyの発行済み資本金の最大100％を取得する権利をCanopy Growthの完全子会社を通じて提供する正式契約を締結したことを発表しました。これにより、同社は市場での事業を拡大することができました。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA CANNABIDIOL (CBD) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 BENCHMARKING ANALYSIS
4.2 CBD PRODUCTS, INCLUDING CANNABINOIDS (IN %)
4.3 CBD RAW MATERIAL DEVELOPMENT TREND
4.3.1 MORE CONTROLLED CBD LEVELS:
4.3.2 CBD AND GENETICS:
4.3.3 ADVANCEMENTS MADE IN EXTRACTION:
4.3.4 NANOTECHNOLOGY
4.3.5 CONCLUSION
4.4 COMPANY POSITIONING GRID
4.4.1 NORTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY LANDSCAPE
4.4.1.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
4.4.1.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
4.4.1.3 COMPANY SHARE ANALYSIS: EUROPE
4.4.1.4 COMPANY SHARE ANALYSIS: SOUTH AMERICA
4.4.2 COMPANY’S CURRENT VENDORS
4.5 OVERALL VOLUME (KILO TONS) & QUANTITY OF COMPLETED TRANSACTIONS: NORTH AMERICA CANNABIDIOL (CBD) MARKET
4.6 LIST OF COUNTRIES THAT LEGALIZED CANNABIDIOL (CBD)
4.7 REGULATION COVERAGE
4.8 IMPORT & EXPORT REGULATION
4.8.1 IMPORT REGULATIONS
4.8.2 EXPORT REGULATIONS
4.9 IMPORT STANDARDS
4.1 GOVERNMENT POLICIES
4.11 QUALIFICATION/CERTIFICATION REQUIRED
4.12 NORTH AMERICA CANNABIDIOL (CBD) MARKET: PRICING ANALYSIS & DEAL PRICING
4.13 RAW MATERIAL EXTRACTOR POSITIONING GRID
4.13.1 KEY EXTRACTION
4.13.2 LINE CAPABILITY
4.14 TECHNOLOGICAL ADVANCEMENTS:
4.15 VENDOR/ DISTRIBUTOR SHARE ANALYSIS
4.16 VENDOR/DISTRIBUTOR KEY BUYERS
5 CLIMATE CHANGE SCENARIO: NORTH AMERICA CANNABIDIOL (CBD) MARKET
5.1 ENVIRONMENT CONCERNS-
5.2 INDUSTRY RESPONSE-
5.3 GOVERNMENT INITIATIVES
5.4 ANALYST RECOMMENDATIONS
6 SUPPLY CHAIN OF THE NORTH AMERICA CANNABIDIOL (CBD) MARKET
6.1 LOGISTIC COST SCENARIO
6.2 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN DEMAND FOR CBD IN HEALTH & FITNESS
7.1.2 IMPROVING GOVERNMENT APPROVALS AND REGULATIONS FOR CBD PRODUCTS
7.1.3 THERAPEUTIC PROPERTIES OF CBD OIL
7.1.4 CONSUMERS' SHIFT TOWARDS LEGALLY PURCHASING CANNABIS FOR MEDICAL AS WELL AS RECREATIONAL USE
7.2 RESTRAINTS
7.2.1 HIGH COST OF CBD PRODUCTS
7.2.2 AVAILABILITY OF COUNTERFEIT AND SYNTHETIC PRODUCTS IN THE MARKET
7.3 OPPORTUNITIES
7.3.1 INCREASING INVESTMENTS IN THE DEVELOPMENT OF NEW CBD BASED PRODUCTS
7.3.2 GROWING MEDICAL APPLICATIONS OF CBD
7.4 CHALLENGES
7.4.1 SIDE EFFECTS ASSOCIATED WITH CBD OIL
7.4.2 BARRIERS IN TERMS OF MARKETING OF CBD
8 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY SOURCE
8.1 OVERVIEW
8.2 HEMP
8.3 MARIJUANA
9 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 CANNABIDIOL (CBD) OIL
9.2.1 CARBON DIOXIDE EXTRACTION
9.2.2 STEAM DISTILLATION
9.2.3 SOLVENT EXTRACTION
9.2.4 OTHERS
9.3 CANNABIDIOL (CBD) ISOLATES
9.4 CANNABIDIOL (CBD) CONCENTRATES
9.5 OTHERS
10 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY NATURE
10.1 OVERVIEW
10.2 ORGANIC
10.3 INORGANIC
11 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY GRADE
11.1 OVERVIEW
11.2 FOOD GRADE
11.3 THERAPEUTIC GRADE
12 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 TINCTURE
12.3 FOOD
12.3.1 CHOCOLATE & CONFECTIONERY
12.3.1.1 CANDY
12.3.1.2 CHOCOLATE
12.3.1.3 CHEWS
12.3.1.4 GUMMIES
12.3.1.5 OTHERS
12.3.2 HONEY
12.3.3 DAIRY BASED EDIBLE
12.3.3.1 MILK
12.3.3.2 ICE CREAM
12.3.3.3 OTHERS
12.3.4 SAUCES AND SEASONINGS
12.3.5 BAKERY EDIBLE
12.3.5.1 COOKIES AND BISCUITS
12.3.5.2 BROWNIES
12.3.5.3 OTHERS
12.3.6 OTHERS
12.3.7 PHARMACEUTICALS
12.3.7.1 DRAVET SYNDROME
12.3.7.2 MULTIPLE SCLEROSIS DRUG APPLICATIONS
12.3.7.3 NEUROLOGICAL DRUG APPLICATIONS
12.3.7.4 CANCER DRUG APPLICATIONS
12.3.7.5 OTHERS
12.3.8 DIETARY SUPPLEMENTS
12.3.8.1 CAPSULES
12.3.8.2 GUMMIES
12.3.8.3 OTHERS
12.3.9 BEVERAGES
12.3.9.1 NON-ALCOHOLIC BEVERAGES
12.3.9.1.1 ENERGY DRINKS
12.3.9.1.2 SOFT DRINKS
12.3.9.1.3 RTD COFFEE
12.3.9.1.4 TEA
12.3.9.1.5 SPARKLING WATER
12.3.9.1.6 OTHERS
12.3.9.2 FLAVORED DRINKS
12.3.9.2.1 ORANGE
12.3.9.2.2 LEMON
12.3.9.2.3 BERRIES
12.3.9.2.4 COCONUT
12.3.9.2.5 OTHERS
12.3.9.3 ALCOHOLIC BEVERAGES
12.3.9.3.1 BEER
12.3.9.3.2 WINE
12.3.9.3.3 OTHERS
12.3.9.4 OTHERS
12.3.10 TOPICAL
12.3.10.1 LOTION
12.3.10.2 SALVE
12.3.10.3 LIP BALM
12.3.10.4 OTHERS
12.3.11 OTHERS
12.3.11.1 VAPES
12.3.11.2 CIGARETTES
12.3.11.3 SPA AND RECREATION
13 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 CURALEAF
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 TILRAY
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 JAZZ PHARMACEUTICALS, INC.
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 CANOPY GROWTH CORPORATION
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 AURORA CANNABIS.
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 CHARLOTTE’S WEB.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 CV SCIENCES, INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 DIAMOND CBD.
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 ELIXINOL WELLNESS LIMITED
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENTS
15.1 ENDOCA.
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 FREEDOM LEAF, INC
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 GAIA HERBS HEMP
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 GREEN ROADS.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 GROFF NORTH AMERICA HEMPLEX
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 HEXO CORP.
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENTS
15.16 HEALTHY FOOD INGREDIENTS, LLC.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 ISODIOL INTERNATIONAL INC
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 JOY ORGANICS
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENTS
15.19 KAZMIRA
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
15.2 KOI CBD
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 MEDICAL MARIJUANA, INC.
15.21.1 COMPANY SNAPSHOT
15.21.2 EVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENTS
15.22 MEDTERRA CBD
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENTS
15.23 NULEAF NATURALS, LLC
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENTS
15.24 PHOENA HOLDINGS INC.
15.24.1 COMPANY SNAPSHOT
15.24.2 PRODUCT PORTFOLIO
15.24.3 RECENT DEVELOPMENTS
15.25 THE CRONOS GROUP
15.25.1 COMPANY SNAPSHOT
15.25.2 REVENUE ANALYSIS
15.25.3 PRODUCT PORTFOLIO
15.25.4 RECENT DEVELOPMENTS
15.26 VIVO CANNABIS INC.
15.26.1 COMPANY SNAPSHOT
15.26.2 REVENUE ANALYSIS
15.26.3 PRODUCT PORTFOLIO
15.26.4 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
表のリスト
TABLE 1 BENCHMARK ANALYSIS
TABLE 2 AVERAGE VOLUME TREND FOR NORTH AMERICA CANNABIDIOL (CBD) MARKET (KILO TONS)
TABLE 3 THE FOLLOWING ARE THE PRICES OF PRODUCTS OFFERED BY THE COMPANIES:
TABLE 4 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA HEMP IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA MARIJUANA IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 10 NORTH AMERICA CANNABIDIOL (CBD) ISOLATES IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA CANNABIDIOL (CBD) CONCETRATES IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA OTHERS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA ORGANIC IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA INORGANIC IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA FOOD GRADE IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA THERAPEUTIC GRADE IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 20 NORTH AMERICA TINCTURE IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA FOOD IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA FOOD IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA PHARMACEUTICALS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA TOPICAL IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA TOPICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA OTHERS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 NORTH AMERICA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 39 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 50 NORTH AMERICA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 51 NORTH AMERICA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 52 NORTH AMERICA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 53 NORTH AMERICA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 NORTH AMERICA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 55 NORTH AMERICA TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 56 NORTH AMERICA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 57 NORTH AMERICA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 58 U.S. CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 59 U.S. CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 60 U.S. CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 61 U.S. CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 62 U.S. CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 63 U.S. CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 64 U.S. FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 65 U.S. CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 66 U.S. BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 67 U.S. DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 68 U.S. BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 69 U.S. ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 70 U.S. NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 71 U.S. FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 72 U.S. PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 73 U.S. TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 74 U.S. DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 75 U.S. OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 76 CANADA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 77 CANADA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 78 CANADA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 79 CANADA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 80 CANADA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 81 CANADA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 82 CANADA FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 83 CANADA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 84 CANADA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 85 CANADA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 86 CANADA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 87 CANADA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 88 CANADA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 89 CANADA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 90 CANADA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 91 CANADA TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 92 CANADA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 93 CANADA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 94 MEXICO CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 95 MEXICO CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 96 MEXICO CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 97 MEXICO CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 98 MEXICO CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 99 MEXICO CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 100 MEXICO FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 101 MEXICO CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 102 MEXICO BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 103 MEXICO DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 104 MEXICO BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 105 MEXICO ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 106 MEXICO NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 107 MEXICO FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 108 MEXICO PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 109 MEXICO TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 110 MEXICO DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 111 MEXICO OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
図表一覧
FIGURE 1 NORTH AMERICA CANNABIDIOL (CBD) MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA CANNABIDIOL (CBD) MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA CANNABIDIOL (CBD) MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA CANNABIDIOL (CBD) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 NORTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA CANNABIDIOL (CBD) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA CANNABIDIOL (CBD) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 NORTH AMERICA CANNABIDIOL (CBD) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA CANNABIDIOL (CBD) MARKET: SEGMENTATION
FIGURE 10 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NORTH AMERICA CANNABIDIOL (CBD) MARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 11 THE INCREASING DEMAND FOR CANNABIDIOL (CBD) DUE TO ITS HEALING PROPERTIES AND HEALTH AND WELLNESS PURPOSES IS HIGH, WHICH IS THE MAJOR FACTOR DRIVING THE MARKET IS EXPECTED TO DRIVE THE NORTH AMERICA CANNABIDIOL (CBD) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 HEMP IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CANNABIDIOL (CBD) MARKET IN 2022 & 2029
FIGURE 13 NORTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)
FIGURE 14 NORTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)
FIGURE 15 EUROPE CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)
FIGURE 16 SOUTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)
FIGURE 17 NORTH AMERICA CANNABIDIOL (CBD) MARKET: VENDOR/ DISTRIBUTOR SHARE ANALYSIS (%)
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA CANNABIDIOL (CBD) MARKET
FIGURE 19 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY SOURCE, 2021
FIGURE 20 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY SOURCE, 2022-2029 (USD MILLION)
FIGURE 21 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY SOURCE, CAGR (2022-2029)
FIGURE 22 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY SOURCE, LIFELINE CURVE
FIGURE 23 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, 2021
FIGURE 24 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 25 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 26 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 27 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY NATURE, 2021
FIGURE 28 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY NATURE, 2022-2029 (USD MILLION)
FIGURE 29 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY NATURE, CAGR (2022-2029)
FIGURE 30 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY NATURE, LIFELINE CURVE
FIGURE 31 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY GRADE, 2021
FIGURE 32 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY GRADE, 2022-2029 (USD MILLION)
FIGURE 33 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY GRADE, CAGR (2022-2029)
FIGURE 34 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY GRADE, LIFELINE CURVE
FIGURE 35 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY APPLICATION, 2021
FIGURE 36 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 37 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 38 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 39 NORTH AMERICA CANNABIDIOL (CBD) MARKET: SNAPSHOT (2021)
FIGURE 40 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY COUNTRY (2021)
FIGURE 41 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY COUNTRY (2022 & 2029)
FIGURE 42 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY COUNTRY (2021 & 2029)
FIGURE 43 NORTH AMERICA CANNABIDIOL (CBD) MARKET: BY SOURCE (2022-2029)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
